Arrow announces UK distribution of Finasteride
Arrow
announces UK
distribution of Finasteride 5mg Tablets on day one following patent expiry.
Arrow Generics has once again
achieved ‘first to market’ success with a day one launch of its Finasteride 5mg
Tablets in the UK, following the expiry of the Finasteride molecule. The
product will be available from most UK wholesalers, in blister packs of
28, from Tuesday 29th May 2007.
Finasteride is the latest, in
what is now a series of successful patent expiry day one launches for Arrow
Generics. Previous day one launches for Arrow include important molecules such
as Amlodipine (maleate and besylate), Carvedilol, Doxazosin, Fosinopril, Lamotrigine
(both conventional and dispersible), Lansoprazole, Mirtazapine, Pravastatin, Sertraline,
Simvastatin and Terbinafine.
For further information please
contact us via the web page.
P
ublished 2007-05-27 07:30:00
